Close

ORA Plans To Fund Telehealth Expansion In Southeast Asia

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

ORA, which is one of the best telehealth platforms in Singapore, has garnered USD10M in a Series A funding round. It has set the record for the largest telehealth Series A in Southeast Asia. The round, spearheaded by TNB Aura and Antler, included contributions from Kairous Capital, Gobi Partners, and GMA Ventures, raising the total funds acquired to more than $17 million.

As the fastest-growing and largest vertically-integrated telehealth platform in Southeast Asia, ORA has conducted more than 250,000 consultations since its launch in 2021, experiencing consistent monthly growth. It has introduced three brands catering to patients with chronic conditions, focusing on accessibility, convenience, and personalization. Modules present a cutting-edge online dermatology experience, delivering personalized prescription skincare encompassing a wide range of 676 unique formulations. andSons specializes in male health solutions, while OVA focuses on female reproductive healthcare.

ORA plans to utilize its recent $10 million Series A funding to expand into new territories and introduce new offerings. In the coming months, ORA’s brands will be available in 1,300 tier-one retail stores, making their accessible and medically-backed products more widely accessible. The company also sees potential for expansion into regions such as the Gulf Cooperation Council (GCC), including Bahrain, Saudi Arabia, Oman, Kuwait, Qatar, and the United Arab Emirates.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back